Observations placeholder
Byetta
Identifier
018134
Type of Spiritual Experience
Background
A description of the experience
Exenatide arketed as Byetta, Bydureon) is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2. Exenatide in its Byetta form is administered as a subcutaneous injection (under the skin) of the abdomen, thigh, or arm, any time within the 60 minutes before the first and last meal of the day
On Dec, 31, 2016 56,104 people reported to have side effects when taking Byetta.
Among them, 47 people (0.08%) have Hallucination
Time on Byetta when people have Hallucination :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination29.41%41.18%17.65%11.76%0.00%0.00%0.00%
On Sep, 21, 2015: 48,636 people reported to have side effects when taking Byetta. Among them, 232 people (0.48%) have Death.
Time on Byetta when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death25.86%31.03%22.41%1.72%15.52%3.45%0.00%